Wednesday, March 20, 2013

When Purpose is large and Cause is Big, Then People will join you

Summary of Prof. Samir k Brahmachari's Speeches
(Director General, CSIR and Chief Mentor-OSDD)
 
 
WHAT IS OSDD?
  • OSDD is a movement, not a only research project, done with passion and full of love.
  • An inclusive innovation model
  • It Works with students hungry to learn.
  • OSDD aims to collaborate with people of the world to make affordable healthcare.

OBJECTIVES OF OSDD:
  • To change the entire education system by transforming the education through web by new way of thinking, collective learning and problem solving.
  • To not only deliver the drug but to change the attitude of people.
  • To make an ideal drug – a drug which cures just after intake.

MYCOBACTERIUM TUBERCULOSIS AS FIRST TARGET:
  • India is the biggest affected country of Tuberculosis in the world. So has obligation to discover drug for this disease.

CHALLENGES:
  • How the chemical molecule (drug) works?

(Drug is a small molecule which inhibits the function of an unwanted biological function without affecting other biological functions)
Chemistry is nothing but interaction of molecules with complementary charge and shape leading to sometimes a new product. When new product is expressed, we say a chemical reaction has occurred. But when no new product is formed we call it, chemical binding has happened.
The dream drug molecule is the one which exactly go and fit and will leave rest which are not there.

 
  • We have to understand the biological system to discover the chemistry of life and make discovery.
  • How to make new drugs cheaper using new mechanisms and IPR free? (Moral of OSDD)


HISTORY OF CHEMICAL LABORATORY ESTABLISHMENT IN INDIA:
  • In 1950’s Pt. Jawaharlal Nehru realized to make chemical laboratory in India, which will actually make public funded drug discovery.
  • No one in the world did it before.
  • Till 1970 Indian’s were paying more for drug than any other country.
  • Mrs Indira Gandhi brought in 1970’s legislation the patent law, which allowed the scenario change, which led to process patent, product patent and new chemistry.

QUESTIONS:

Question 1 –Why, what and how open source drug discovery? 
  • In a single room people from different background won’t agree on the same topic as they have different views, so have a cyber space.
  • Scientists and researchers need to show different sides of their face to people from different background to make them understand what OSDD is and how they can contribute to it.

Question 2- What is Cheminformatics?
  • Cheminformatics is nothing but designing a structure, charge and shape in such a way that increases the specificity and selectivity of its targets, once target is decided.

Question 3– Can we connect our brain and computers to solve the problems in cheminformatics? (Although computers are slower than brain)
  • Instead of screening the toxicity of drug (previously), why not to search new non-toxic targets. So we will have new targets, new molecules (drugs) and known molecules for the new targets.

Question 4 – Can we find all the proteins which are unstructured?

Question 5– Why a drug should show 100% inhibition? Why not 90% or less?

Question 6- Can we build function of kidney in computers?

Question 7- Can we build process of absorption in the blood stream in computers?


KEEP IT SIMPLE:
  • Life is nothing but chemistry of few elements.
  • Nature is the cleverest scientist, with millions of years of experience of evolution, it has evolved perfect machines.
  • We try to fool these machines in one way, we are fighting with these machines (Example - Mycobacterium Tuberculosis), but these microbes have perfected them to live in our body.
  • Therefore we need thousands of young minds to look at this problem without any bias and solve it from the root.
  • Most of the biological molecules are so diverse, that we can’t figure it out. So what we perceive goes in different direction.
  • Try to perceive things in your own way. Everyone has got their different perception to a particular subject.
  • Learning and doing things in different ways we learn it faster and better.
  • Students should think out of canonical and conventional teaching.


NEW HYPOTHESIS:
 
  • To target a non-active site, when a drug binds with a non-active site it halt the process at active site.
  • To make sure that protein being targeted should be absent in gut flora, mouth flora and absent everywhere.

CROWDSOURCING APPROACH:
  • Open science is looking for not only a single noble laureate but a group of noble laureates.
  • When purpose is large and cause is big, then people will join you.

EXPECTATIONS FROM OSDD COMMUNITY:
  • To make people realize importance of love, sharing, caring and education.
  • We need contributors to discover new lead by new way of thinking, learning.
  • One day OSDD will make difference in availing drugs at affordable rates.
  • If we can make a difference, India will be a different country.
 
DIFFERENT MEANINGS OF OSDD:
  • Open source drug discovery
  • Open source drug development
  • Open source drug delivery
  • Open source disease diagnostic

Contributors should concentrate on first definition i.e. – open source drug discovery.

Thursday, February 7, 2013

OSDD OPEN LAB FOR SCIENCE PASSIONATES

“ I believe that affordable healthcare is a right for all. But, pragmatically speaking, when it comes to health, we need to have a balanced view between health as a right and health as a business.”-
Samir. K Brahmachari                                                                                                                                                                                                                                                                                                                   Chief Mentor, OSDD



 “Even if the open windows of science at first make us shiver after the cozy indoor warmth of traditional humanizing myths, in the end the fresh air brings vigor, and the great spaces have a splendor of their own.”  -Bertrand Russell

CSIR- OSDD has established a CSIR-OSDD Research Unit at Indian Institute of Science (IISc), Bangalore; as an open lab for facilitating OSDD’s drug discovery efforts. The Unit will henceforth coordinate the informatics and wet-lab activities of OSDD. Members of OSDD community are welcome to come in and spent time on any research problem posted on the Sysborg portal                                                                                                                                                                              
OSDD is a CSIR-led Team India consortium with a global partnership. Its vision is to provide affordable healthcare to the developing world by providing a global platform where the best minds can collaborate & collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected tropical diseases like malaria, tuberculosis, leishmaniasis, etc. It is a concept to collaboratively aggregate the biological and genetic information available to scientists in order to hasten the discovery of drugs. This will provide a unique opportunity for scientists, doctors, technocrats, students and others with diverse expertise to work for a common cause.
OSDD is a community of students, scientists, researchers, academicians, institutions, corporations and anyone who is committed to discovery of drugs in an open source mode. Open source drug discovery emphasizes integrative science through collaboration, open sharing and taking up multifaceted approaches and getting the benefits from advances on different fronts of new drug discovery.

What is an open lab?
OpenLab is a new research initiative for interdisciplinary and collaborative projects and it is a public private partnership where people from different sectors can contribute for a common cause. It allows knowledge sharing and brings different minds to work together. Any enthusiastic scientist/research fellow can work for a noble cause wherein the interested person can avail all the required facilities to contribute towards the work. In-silico work would be supported with the provision of tools and softwares that would help in a particular project. An open lab will help pooling in new ideas and working for the same. It gives an opportunity for a research fanatic to apply and implement his ideas with the available resources. Individual talent can be motivated through an open lab  system and drive the idea further. 

DIFFERENCES BETWEEN OPEN LAB AND TRADITIONAL LAB















Objectives of Open source drug discovery
The open Source drug discovery initiative would establish a novel open platform for both computational and experimental technologies to make drug discovery for infectious/neglected diseases, cost effective and affordable to the people of developing world. “Open-Source drug discovery” will be a program to find cures for diseases that affect the world`s poorest of the poor. As a first phase, drugs against Mycobacterium tuberculosis including drug resistant and latent tuberculosis will be undertaken with the following major objectives:
  • Development of a web-based portal for data deposition, exchange, evaluation         and tabulation for analysis.
  •  To create a comprehensive System Biology approach for drug discovery.
  •  Human resource development with emphasis on encouraging young minds.     
  •  Intellectual property protection to the extent its support public good.
  • Academia-industry partnership i.e., Public-Private Partnership (PPP) in open source mode.
  • To establish an International Collaborative Centre for Affordable Health (ICCAH), which will operate with Government, International and Philanthropic funding.

       K.ASHISH
       AIMIT, St.Aoyisus college

Tuesday, December 4, 2012



TB VOICES







NEED FOR NEW DRUGS FOR TUBERCULOSIS

 

are u interested to join

OSDD MEDIA FORUM 

click 

  JOIN OSDD MEDIA FORUM 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Wednesday, November 7, 2012

YouTube Contest - The Need of New Drugs for TB



An Open Call to All ....


TB is a curable infection that affects more than 2 billion people across the  globe annually, claiming almost 1.4 million lives. It is estimated that TB claims one life every 20 seconds around the globe. In India alone, over 1000 lives succumb to TB everyday (2 deaths every 3 minutes). Existing TB treatment makes use of combinatorial therapy involving 4 medicines and is administered for a period of 6 to 9 months under the direct observation of a physician (DOTS).These drugs were discovered in the middle of 20th century. The treatment regimen is too long and risk prone and the inadequate administration of 
existing treatment has resulted in the emergence of MDR (multiple drug 
resistant) TB and XDR (extremely drug resistant) TB. The emergence of drug 
resistant cases of TB, and lack of any new drugs since past 60 years, 
demands the discovery of more effective, novel drugs. 


In order to create awareness about the need of new drugs for TB and to bring in more eyeballs to focus on the problem of TB,
Open Source Drug Discovery (OSDD) 
in collaboration with Vigyan Prasar 
is 
organizing a Short Video Competition on “The Need of New Drugs for TB” 
for which prizes will be awarded during the Indian Science Congress 2013. It 
is open to all producers, both private and government; individuals as well 
as production agencies and organisations. Media centres, television 
channels and media schools are also encouraged to participate. The 
participants are requested to upload their videos on YouTube and inform 
the URL through the form which is required to be submitted.






The contest is open to all above 18 years of age (In India)
Contest Open Now !!! All entries for the competition should be submitted by 5 pm 30th November
2012.
Awards

a. First Prize 50,000/-
b. Second Prize 25,000/-
c. Third Prize 15,000/-
d. 20 Merit Prizes 10,000/- each


For more details and to download the entry form...please visit : http://www.osdd.net or http://www.vigyanprasar.gov.in


Thursday, November 1, 2012

OSDD cheminformatics at Imtech







       OSDD Cheminformatics started another unit  at GN Ramachandran protein centre at imtech  Chandigarh under the leader ship of  Dr GPS  Raghava  Imtech Chandigrah  .  Dr Narahari Sastry  (iict Hyderabad ) , Dr Kartikeyan (NCl Pune ) ,  Dr Andrew lynn  (JNU)   Dr jaleel (OSDD  ) will  collaborate   with  OSDD  team at Imtech  Chandigarh 




Wednesday, October 24, 2012



Youtube Video Competition on Need of New Drugs for TB
Zakir Thomas

Tuberculosis is a curable infectious disease. Yet every 20 seconds it kills someone somewhere in the world. In India alone two people die of TB every three minutes. However we do not hear a media outcry or a newsblitz on these deaths that regularly happen, day after day, year after year. This is because TB related deaths are so regular that it has ceased to be news.

The current TB therapy is a combination of four drugs (rifampicin, isoniazid, pyrazinamide, ethionamide) administered over a period of six to nine months. This therapy is to be administered under the direct supervision of a physician, called, Directly Observed Therapy, short duration (DOTS) (it is left to you to wonder who is the optimist who chose a six month treatment as a short duration therapy).   DOTS do have issues of hepatotoxicity and the long duration itself leads to treatment drop out and failures. Treatment failures and dropouts lead to multidrug resistant TB (MDRTB) which requires a lengthier (18 months) recourse more toxic second line therapy. Emergence of extremely drug resistant (XDRTB) is a serious cause of worry as many drugs are ineffective. MDR and XDR arises when common TB goes untreated or when person drops out of treatment.

The urgent need is to find new and more effective drugs that are of shorter duration and less toxic.

The DOTS drugs were discovered in the fifties and the sixties of the last century. Over more than four decades no new first line drugs have been invented. There are several reasons for this. The inventive pharmaceutical companies do not have adequate incentives to invest in the drugs for TB as the market size of TB is estimated  to be less than four hundred dollars while the estimated cost of drug development is much higher.

It is not insignificant that most people who contract TB or die of it are from the poorer sections of the society living in the developing and least developed regions of the world. They do not have a voice to say that that all lives, wherever you belong to, have equal value.

To enable you to give a voice to the voiceless TB patients, OSDD (www.osdd.net) along with Vigyan Prasaar (http://www.vigyanprasar.gov.in/index.asp) has organized a Youtube based short video competition. This competition is open for entries till 26 November, 2012. The prizes will be determined by an experienced jury who will also consider the number of online ‘likes’ you have received for your video. There are first, second and third prizes and 20 merit prizes to win. Anyone above 18 can participate. The duration of the movie shall be less then 5 minutes. You may even shoot from your mobile and upload like a citizen journalist, fill the form and submit it for competition. More details are at:  http://www.osdd.net/home/student-corner/student-corner-news-updates/shootuploadwinyoutubevideocompetitionontheneedofnewdrugsfortb

However, this is more than a competition. It is about giving a voice to the unheard and suffering TB patients. It is about a category of diseases called neglected diseases. It is about creating awareness about the desperate need of new drugs for TB

It will give  you a chance to speak up of the need of new drugs for TB.

  
To know more about TB, please visit


To read about TB in India, please see a recent series in The Hindu
India’s Tuberculosis Challenge by R Prasad
India has highest number of Multi Drug Cases in South Asia by Aarti Dhar
http://www.thehindu.com/news/national/article3156259.ece